ELITE PHARMACEUTICALS INC /NV/ cotiza a 0.26 USD y tiene una capitalización bursátil de $280M. En los últimos 12 meses ha facturado $141M con un margen de flujo de caja libre del 15.3%. Cotiza a 16.0 veces su flujo de caja libre (P/FCF) y a un PER de 4.9. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. It owns, licenses, manufactures, and sales of generic, oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15m…
| Periodo | 2026-08 | 2008-02 | 2007-11 | 2007-08 |
|---|---|---|---|---|
| Real | — | $-0.15 | $-0.29 | $-0.21 |
| Estimado | — | $-0.30 | $-0.18 | $-0.13 |
| Sorpresa | — | +50.0% | -61.1% | -61.5% |
| Métrica | ELTP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 50.4% | 57.0% | -6.6% |
| Operating Margin | 33.0% | -38.6% | +71.6% |
| Net Margin | 30.1% | -33.6% | +63.7% |
| FCF Margin | 15.3% | -13.9% | +29.2% |
| ROE | 45.4% | -40.4% | +85.8% |
| ROA | 32.5% | -32.0% | +64.5% |
| Current Ratio | 6.45 | 2.84 | +3.61 |
| Debt / Equity | — | 0.28 | — |